Cellseed Enterprises Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.30 M
as on 24-10-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 86.59 Cr
as on 24-10-2024
- Revenue -99.20%
(FY 2023)
- Profit -124.27%
(FY 2023)
- Ebitda 59.83%
(FY 2023)
- Net Worth -6.13%
(FY 2023)
- Total Assets -12.09%
(FY 2023)
About Cellseed Enterprises
The Corporate was formerly known as Adips Formulations Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹86.59 Cr.
Rajaram Chavan, Rajeev Kaushal, and Arti Iswalkar serve as directors at the Company.
- CIN/LLPIN
U24232UR2006PTC031642
- Company No.
031642
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- LocationHaridwar, Uttarakhand
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cellseed Enterprises?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajaram Chavan  | Additional Director | 09-Nov-2022 | Current |
| Rajeev Kaushal | Director | 21-Oct-2019 | Current |
| Arti Iswalkar | Director | Current |
Financial Performance and Corporate Structure Insights of Cellseed Enterprises.
Cellseed Enterprises Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.2% decrease. The company also saw a substantial fall in profitability, with a 124.27% decrease in profit. The company's net worth dipped by a decrease of 6.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellseed Enterprises?
In 2023, Cellseed Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Sep 2021 | ₹2.45 Cr | Open |
Others Creation Date: 25 Sep 2021 | ₹1.12 Cr | Open |
Export Import Bank Of India Creation Date: 18 Feb 2015 | ₹11.00 Cr | Open |
How Many Employees Work at Cellseed Enterprises?
Unlock and access historical data on people associated with Cellseed Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellseed Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellseed Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
